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Abstract
The aim of this study was to determine the effects of vitamin E (α-tocopherol) on the low density
lipoprotein (LDL) receptor, a cell surface protein which plays an important role in controlling blood
cholesterol. Human HepG2 hepatoma cells were incubated for 24 hours with increasing amounts
of α, δ, or γ-tocopherol. The LDL receptor binding activity, protein and mRNA, 3-hydroxy-3-
methylglutaryl coenzyme A (HMG-CoA) reductase mRNA, cell cholesterol and cell lathosterol
were measured. The effect of α-tocopherol was biphasic. Up to a concentration of 50 µM, α-
tocopherol progressively increased LDL receptor binding activity, protein and mRNA to maximum
levels 2, 4 and 6-fold higher than control, respectively. The HMG-CoA reductase mRNA and the
cell lathosterol concentration, indices of cholesterol synthesis, were also increased by 40% over
control by treatment with 50 µM α-tocopherol. The cell cholesterol concentration was decreased
by 20% compared to control at 50 µM α-tocopherol. However, at α-tocopherol concentrations
higher than 50 µM, the LDL receptor binding activity, protein and mRNA, the HMG-CoA reductase
mRNA and the cell lathosterol and cholesterol concentrations all returned to control levels. The
biphasic effect on the LDL receptor was specific for α-tocopherol in that δ and γ-tocopherol
suppressed LDL receptor binding activity, protein and mRNA at all concentrations tested despite
the cells incorporating similar amounts of the three homologues. In conclusion, α-tocopherol,
exhibits a specific, concentration-dependent and biphasic "up then down" effect on the LDL
receptor of HepG2 cells which appears to be at the level of gene transcription. Cholesterol
synthesis appears to be similarly affected and the cell cholesterol concentration may mediate these
effects.
Introduction
It has been known for over 60 years that the vitamin E (α-
tocopherol) status of rabbits can affect their plasma cho-
lesterol concentration. In 1936, Morgulis and Spencer [1]
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reported that the plasma cholesterol was twofold higher
than normal in rabbits made deficient in vitamin E and
that dietary replenishment of the vitamin normalised the
cholesterol concentration. This effect was later confirmed
by others in the rat [2–4] as well as in the rabbit [5–7]. In
animal models of diet-induced hypercholesterolaemia,
where the animals are not deficient in vitamin E, α-toco-
pherol supplementation also often decreases plasma cho-
lesterol [8–12]. This is not always the case however; in
some studies either no change [13–15] or even an increase
[16] in plasma cholesterol was observed. In the rat how-
ever, a concomitant deficiency in selenium may be more
relevant to increases in plasma cholesterol than the in-
duced deficiency in vitamin E [17]
Changes in the plasma cholesterol concentration may re-
sult from effects the vitamin has on liver cholesterol me-
tabolism. Hepatic cholesterol synthesis has been found to
be increased in vitamin E-deficient rabbits [5] and the
conversion of cholesterol into bile acids was observed to
be decreased [5,6]. Such an increase in cholesterolgenesis
and a decrease in cholesterol catabolism is consistent with
the increase in liver cholesterol concentration found in
the vitamin E-deficient rat [3,4].
There is however no data on the effects of α-tocopherol,
the biologically active homologue of vitamin E, [18] on
the hepatic low density lipoprotein (LDL) receptor which
is well known to play a major role in the control of plasma
cholesterol [19,20]. The importance of the LDL receptor is
most clearly seen in the human genetic disorder called fa-
milial hypercholesterolaemia where a deficiency in the re-
ceptor causes high levels of plasma cholesterol which lead
to the premature development of atherosclerosis [20]. The
LDL receptor is also highly regulated in that various die-
tary and pharmaceutical agents can affect its expression
[19,20]
The aim of the present study was therefore to determine
whether vitamin E could regulate the LDL receptor. Cul-
tured human HepG2 hepatoma cells, highly differentiat-
ed hepatocytes known to express lipoprotein receptors,
[21–23] were grown in the absence of added vitamin E.
Three naturally occurring vitamin E homologues, α, δ and
γ-tocopherol [18] were tested for their effects on the
HepG2 cell LDL receptor mRNA, protein and LDL-bind-
ing activity. The effect of α-tocopherol on the mRNA of 3-
hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) re-
ductase, the rate-limiting enzyme in cholesterol biosyn-
thesis, and on the cellular concentration of lathosterol, an
index of cholesterol synthesis, was also determined. The
cell's cholesterol concentration was also measured.
Methods and materials
Cell culture
The HepG2 cells were grown under 5% CO2 at 37°C in
Dulbecco's Modified Eagles Medium (DMEM) supple-
mented with 12 µg/ml penicillin, 16 µg/ml gentamicin,
20 mM HEPES buffer, 10 mM NaOH, 2 mM L-glutamine
and 10% (v/v) fetal calf serum (FCS) (Commonwealth Se-
rum Laboratories, Melbourne, Australia) as previously de-
scribed [21–23]. For enrichment experiments, cells were
grown to 80–90% confluency, and varying amounts of α,
δ or γ-tocopherol (Purity 95%; Sigma-Aldrich, Castle Hill,
Australia) in ethanol were added to supplemented DMEM
and the cells were incubated in the media for 24 h. The
cells were then extensively washed in phosphate buffered
saline (PBS: 10 mM phosphate, 154 mM NaCl, pH 7) be-
fore being scraped from the flasks and resuspended in
PBS. Cell viability was assessed using the trypan blue dye
exclusion test. Cellular protein was determined using the
method of Lowry et al [24].
Cellular Tocopherol Content
The tocopherol content of the cells was measured using
the method of Yang and Lee [25]. Briefly, 1.0 ml of 1%
ascorbic acid in 100% ethanol added to 1.0 ml of cell sus-
pension (Alpha-tocopherol acetate was used as an inter-
nal standard) and heated at 70°C for 2 min; then 0.3 ml
of saturated KOH was added and incubated for 30 min in
a 70°C water bath. After cooling on ice, 1.0 ml distilled
water and 4.0 ml hexane were added and shaken vigor-
ously for 2 min; then the phases were separated by centrif-
ugation at room temperature, 3000 × g for 10 min. An
aliquot of hexane phase (3.0 ml) was pipetted and dried
under a stream of N [2] and redisolved in 0.2 ml metha-
nol. The aliquots (20 ml each) were injected to high per-
formance liquid chromatography (Waters, Milford, MA,
USA) for analysis on a C 18 column (5 mm 3 4.6 mm 3
25 cm) with the mobile phase of methanol-water (95:5)
and detected by a fluorometer set at excitation 205 and
emission 340 nm. The coefficient of variation over two as-
sessments was less than 5%.
LDL receptor binding assay
Human LDL, 1.025 >d > 1.050 g/ml, was isolated from 2–
4 days-old blood (Red Cross, Adelaide, Australia) by se-
quential ultracentrifugation [26] and conjugated to colloi-
dal gold (LDL-gold) as described. [27,28] Freshly
collected and intact HepG2 cells (100 ug of protein) were
incubated for 1 h at room temperature with LDL-gold (20
ug protein/ml) and buffer (60 mM Tris-HCL, pH 8.0, and
20 mg/ml BSA) in a total of 300 ul either in the presence
of 2 mM Ca(NO3)2 to measure total binding or 20 mM
EDTA to measure calcium-independent binding. Cells
were then centrifuged at 400 × g for 10 min, resuspended
and washed in 300 ul of 2 mM Ca(NO3)2 for total binding
or 300 ul of 20 mM EDTA (pH 8.0) for nonspecificNutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/3
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binding. After centrifugation at 400 × g for 10 min, the
cells were resuspended in 120 ul of 4% (w/v) gum arabic
and the cell-bound LDL-gold was quantified using a silver
enhancement solution (IntenSE BL kit, Amersham, Syd-
ney, Australia) and a Cobas Bio autoanalyser (Roche Di-
agnostica, Nutley, NJ). The HepG2 cell LDL receptor
binding activity was taken to be the total binding minus
the calcium-independent binding and expressed as ng
LDL protein bound per mg cell protein (ng LDL/mg cell).
The binding of LDL-gold to the LDL receptor has been
shown to be indistinguishable from the binding of native
or 125I-LDL and the method has been found to be more
sensitive than the 125I-LDL technique [27,28]. The coeffi-
cient of variation for measurement of LDL receptor bind-
ing activity is 10%.
LDL receptor protein mass assay
The HepG2 cells were solubilized by incubation for 12 h
in a solution of 1.5 % (w/v) Triton X-100 containing 50
mM Tris-maleate (pH 6), 2 mM CaCl2, 1 mM phenyl-
methylsulphonyl fluoride (PMSF) and 10 mM n-ethyl-
maleamide. Solubilized cell protein (100 µg) and
rainbow molecular weight-markers (Pharmacia LKB,
Uppsala, Sweden) were separated by electrophoresis on
2–15% sodium dodecyl sulphate (SDS)-polyacrylamide
gradient gels at 30 mA for 5 h. Separated proteins were
electrotransferred at 45 V for 12 h onto 0.45 µm nitrocel-
lulose membranes (Schleicher and Schuell, Dassel, Ger-
many) and the membranes were blocked for one hour at
room temperature in 10 mM Tris-HCL buffer, pH 7.4,
containing 154 mM NaCl and 10% (w/v) skim milk
powder.
After washing in 10 mM Tris-HCL buffer, pH 7.4, contain-
ing 154 mM NaCl and 1% (w/v) skim milk powder, the
membranes were incubated with a polyclonal anti-LDL re-
ceptor antibody (3.7 µg protein/ml in 10 mM Tris-HCL
buffer, pH 7.4, containing 154 mM NaCl and 1% (w/v)
skim milk powder). The antibody was raised in rabbits
against the LDL receptor purified from bovine adrenal
cortex and recognises the LDL receptor of other species
[29,30]. The membranes were then incubated with anti-
rabbit IgG linked to horseradish peroxidase (Amersham,
North Ryde, Australia), diluted 1:5000 in 10 mM Tris-
HCL buffer, pH 7.4 containing 154 mM NaCl and 1% (w/
v) skim milk powder and subsequently washed twice with
10 mM Tris-HCL buffer, pH 7.4, containing 154 mM NaCl
and 2 mM CaCl2. The membranes were then soaked in en-
hanced chemiluminescence substrate solution for horse-
radish peroxidase (ECL detection kit, Amersham, North
Ryde, Australia) and exposed to hyper-film ECL (Amer-
sham, North Ryde, Australia) for 1 to 5 min. The films
were then scanned to determine the intensity of the LDL
receptor protein bands using an LKB Ultrascan XL en-
hanced laser densitometer (Pharmacia LKB Biotechnolo-
gy, North Ryde, Australia) and the measurements in
arbitrary absorbance units were taken as the mass of LDL
receptor protein in the HepG2 cells. The assay was opti-
mised to give a linear response in the range of LDL recep-
tor protein expressed by the HepG2 cells. The coefficient
of variation for measurement of LDL receptor protein
mass is 10%.
LDL receptor mRNA assay
Cellular RNA was isolated from the HepG2 cells using the
procedure of Chomcznski and Sacchi [31] and the LDL re-
ceptor mRNA was measured using reverse transcription
and the polymerase chain reaction (PCR) as modified
from the method of Powell and Kroon [32].
The RNA was reversed transcribed into cDNA along with
a synthetic piece of cRNA, AW109 (Perkin-Elmer Cetus In-
struments, Norwalk, CT) which was used as an internal
standard because it contains primer site sequences unique
to the LDL receptor. The reaction mixture (11.94 µl) con-
tained 1 µl cell total RNA (120 ng/µl), 1 µl of AW109
cRNA (4 × 104 copies/µl), 1 µl PCR buffer (100 mM Tris
HCl, pH 8.3, 500 mM KCL), 2 µl of 25 mM MgCl2, 0.5 µl
of RNasin (20 U/µl, Perkin-Elmer Cetus Instruments,
Norwalk, CT), 0.5 µl of random hexanucleotide primers
(50 µM, Perkin-Elmer Cetus Instruments, Norwalk, CT),
1.5 µl each of 10 mM dGTP, 10 mM dATP and 10 mM
dCTP, 0.94 µl of 10 mM dTTP (Perkin-Elmer Cetus Instru-
ments, Norwalk, CT) and 0.5 µl of Moloney Murine
Leukemia Virus reverse transcriptase (C50 U/µl, Perkin-
Elmer Cetus Instruments, Norwalk, CT). It was then heat-
ed to 23°C for 10 min, 45°C for 15 min, 95°C for 5 min
in a thermal cycler (Perkin-Elmer Cetus Instruments, Nor-
walk, CT) and finally chilled on ice.
The LDL receptor cDNA was then amplified using the
polymerase chain reaction (PCR) to incorporate in its
primer-specific sequence a digoxigenin (DIG)-labelled
dUT. The PCR mixture (20 µl) contained 5 µl of the re-
verse transcription reaction mixture, 0.5 µl of 1 mM dig-
oxigenin-11-dUTP, 2 µl of PCR buffer (100 mM Tris HCl,
pH 8.3, 500 mM KCL), 0.25 µl of AmpliTaq DNA
Polymerase (5 U/µl, Perkin-Elmer Cetus Instruments,
Norwalk, CT), 0.60 µl of the LDL receptor downstream
primer AW125 (25 µM, Perkin Elmer Cetus, Norwalk,
CT), 0.60 µl of the LDL receptor upstream primer AW126
(25 µM, Perkin Elmer Cetus, Norwalk, CT) and 11.05 µl
deionised H2O. The mixture was overlaid with mineral oil
and the amplification was done with a DNA thermal cy-
cler (Perkin Elmer Cetus, Norwalk, CT) using the follow-
ing conditions for 27 cycles: denaturation at 95°C for 1
min followed by primer annealing at 55°C for 1 min and
then extension at 72°C for 1 min. At the end of the 27th
cycle, a final extension period of 10 min at 72°C was
done.Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/3
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Each PCR reaction mixture (10 µl) was size fractionated
by electrophoresis for 90 min at 90 V in 3% (w/v) agarose
gels with 0.8 mM Tris acetate, pH 8.5, and 0.04 mM EDTA
as running buffer. The DNA was then transferred onto
positively charged nylon membranes (Boehringer Man-
nheim, Rose Park, Australia) by blotting for 4 hours in
0.15 M Na3Citrate, pH 7.6 and 1.5 M NaCl. The nylon
membranes were then baked for 1 h at 100°C and rinsed
in 30 mM Na3Citrate, pH 7.6, and 0.3 M NaCl. The mem-
branes were subsequently incubated in 0.1 mM Tris-HCL,
pH 7.5, and 0.1 M NaCl for 5 min at room temperature
and blocked for 30 min at room temperature in 0.1 mM
Tris-HCL, pH 7.5, 0.1 M NaCl and 10% (w/v) skim milk
powder. The membranes were then incubated for 30 min
with an anti-digoxigenin-IgG antibody, conjugated to al-
kaline phosphatase (Boehringer Mannheim), diluted
1:1000 in 0.1 mM Tris-HCL, pH 7.5, 0.1 M NaCl and 1%
(w/v) skim milk powder. The membranes were subse-
quently washed 3 times for 20 min in 0.1 mM Tris-HCL,
pH 7.5, 0.1 M NaCl, incubated in 0.1 M Tris-HCL, pH 9.5,
0.1 M NaCl and 50 mM MgCl2 for 5 min and then soaked
for 5 min in ECL alkaline phosphatase substrate solution
consisting of 100 µg/ml CSPD (disodium 3-(4-methox-
yspiro{1,2-dioxetane-3,2-(5-chloro) tricyclo [3.3.1.1]de-
can}-4-y)phenyl phosphate) (Boehringer Mannheim,
Rose Park, Australia) in 0.1 M Tris-HCL, pH 9.5, 0.1 M
NaCl and 50 mM MgCl2. They were then blotted dried,
sealed in plastic, incubated at 37°C for 20 min and finally
exposed to hyper-film ECL (Amersham, North Ryde, Aus-
tralia) for 5 to 30 min. The films were scanned using the
LKB Ultrascan XL enhanced laser densitometer (Pharma-
cia LKB Biotechnology, North Ryde, Australia) to deter-
mine the intensity of the two bands corresponding to 1)
cellular LDL receptor mRNA at 258 bp and 2) synthetic
AW109 internal standard RNA at 301 bp. The amount of
LDL receptor mRNA in the HepG2 cells was calculated rel-
ative to the intensity of the band for the known amount of
AW109 RNA added as internal standard and was ex-
pressed per µg of cellular total RNA. The assay was opti-
mised to give a linear response in the range of LDL
receptor mRNA expressed by the HepG2 cells. The coeffi-
cient of variation for measurement of LDL receptor mRNA
is less than 7 %.
HMG-CoA reductase mRNA assay
The HMG-CoA reductase mRNA of HepG2 cells was
measured using reverse transcription and the polymerase
chain reaction, as described above for the LDL receptor
mRNA [31,32]. The AW109 cRNA was also used as the in-
ternal standard in this assay because it contains coding se-
quences of the HMG-CoA reductase gene. The same PCR
reaction mixture was used except that HMG-CoA reduct-
ase-specific primers were included, namely AW102 and
AW104 (Perkin Elmer Cetus, Norfolk, CT) as downstream
and upstream primers, respectively. The coefficient of var-
iation for measurement of HMG-CoA reductase mRNA is
8%.
Cholesterol and lathosterol measurements
Cells were frozen at -80°C for at least 24 h and slowly
thawed for sterol analysis. Thawed cells were centrifuged
for 5 min at 400 × g. They were then homogenised by re-
suspending in 1 ml of SDS buffer (0.1% SDS, 1 mM EDTA
and 0.1 M Tris Base, pH 7.4) and taken up in a syringe
with an 18 gauge needle 4–8 times. Cholesterol and la-
thosterol were then extracted using hexane, subjected to
saponification, derivatised using Trisil-TBT (Power Sil-
Prep Kit, Alltech, Deerfield, IL) and measured by gas chro-
matography (GC) as described by Wolthers et al [33]. The
sterol concentrations were expressed relative to the cellu-
lar protein as measured using the method of Lowry et al
[24]. Lathosterol is a precursor in the cholesterol biosyn-
thetic pathway and has been used as an index of cholester-
ol synthesis [34]. The cholesterol in the media was
measured in the same way. The coefficient of variation for
measurement of cholesterol and lathosterol in our labora-
tory is 6%.
Results
Effects of α-tocopherol on the LDL Receptor
After incubation for 24 h in media containing 0 to 100 µM
α-tocopherol, cultured HepG2 cells and their media were
analysed for their vitamin E content. The amount of α-to-
copherol in the cells was found to increase linearly relative
to the concentration added to the media at the start of the
24 h incubation (Fig. 1). The HepG2 cells therefore effec-
tively incorporated α-tocopherol at all concentrations. No
α-tocopherol was detected in cells or in the media of cells
incubated in the absence of added α-tocopherol.
The LDL receptor binding activity of the HepG2 cells incu-
bated for 24 h in media containing 0 to 100 µM α-toco-
pherol was measured as the calcium-dependent binding
of colloidal gold-LDL. The effect of α-tocopherol on this
LDL receptor binding activity was found to be biphasic
(Fig. 2A). In the first phase, the binding activity progres-
sively increased to 120% of control with increasing con-
centrations of α-tocopherol up to 50 µM but, in a second
phase, it progressively decreased from this level to control
values with higher concentrations of the vitamin.
Since changes in LDL receptor binding activity usually re-
flect changes in the number of receptors [20], measured
the relative amounts of LDL receptor protein present in
the HepG2 cells incubated for 24 h in media containing 0
to 100 µM α-tocopherol. Using a polyclonal antibody
against the LDL receptor, a single band was visualized
which corresponded to a protein with the molecular mass
of the LDL receptor, 130 kDa [20,27]. The effect of α-to-
copherol on the LDL receptor protein was also found to beNutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/3
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biphasic (Fig. 2B). The intensity of the LDL receptor band
progressively increased up to 4.5-fold above control with
increasing concentrations of α-tocopherol up to 50 µM
but then decreased from this level with higher concentra-
tions of the vitamin. The biphasic changes observed in the
binding of LDL-gold to the HepG2 cells can therefore be
attributed to biphasic changes in the amount of LDL re-
ceptors present in the cells.
Since changes in both LDL receptor protein and binding
activity usually reflect changes in gene transcription [20],
we measured the relative amounts of LDL receptor mRNA
present in the HepG2 cells incubated for 24 h in media
containing 0 to 100 µM α-tocopherol. The effect of α-to-
copherol on the LDL receptor mRNA was also found to be
biphasic (Fig. 2C). The amount of receptor mRNA pro-
gressively increased up to 6.5-fold above control with in-
creasing concentrations of α-tocopherol up to 50 µM but
then decreased from this level at higher concentrations of
the vitamin. The biphasic changes observed in the binding
of LDL-gold to the HepG2 cells and the amount of LDL re-
ceptor protein present in the cells can therefore be attrib-
uted to biphasic changes in the amount of LDL receptor
mRNA. Furthermore, this suggests a biphasic effect on
gene transcription.
Figure 1
The enrichment of HepG2 cells with α-tocopherol. Cells 
were incubated for 24 h at 37°C in media containing the indi-
cated initial concentrations of α-tocopherol. After 24 h, the 
vitamin content of the cells (● , left y-axis scale) and the con-
centration of α-tocopherol remaining in the media (❍ , right 
y-axis scale) were measured by HPLC as described in Meth-
ods and materials. Values are means of duplicate 
determinations.
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Figure 2
The effect of α-tocopherol on LDL receptor binding activity, 
protein and mRNA of HepG2 cells. Cells were incubated for 
24 h at 37°C in media containing the indicated concentra-
tions of α-tocopherol. The LDL receptor binding activity (A) 
was measured in triplicate using colloidal-gold LDL, the LDL 
receptor protein (B) was measured by western blotting and 
the LDL receptor mRNA (C) was measured using a PCR and 
western blotting technique as described in Methods and 
materials and the data was expressed as the percent differ-
ence (mean ± SEM of three experiments) from the values 
obtained with control cells not pretreated with α-tocophe-
rol. The LDL receptor activity of control cells averaged 30 ± 
4.4 ng LDL/mg cell protein, the LDL receptor protein in con-
trol cells averaged 0.2 ± 0.09 absorbance units and the 
amount of LDL receptor mRNA in control cells averaged 4.0 
± 0.5 × 105 copies/µg RNA.
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Effects of δ – and γ-tocopherol on the LDL Receptor
There are four naturally occurring tocopherols: α-, β-, δ-
and γ-tocopherol [18]. To investigate whether the bipha-
sic regulation of the LDL receptor observed with α-toco-
pherol was a property of other tocopherols, HepG2 cells
were incubated for 24 h in media containing either 0 to
100 µM α-tocopherol, δ-tocopherol or γ-tocopherol. All
three tocopherols were similarly incorporated by the cells
(Fig. 3) with the cellular content of each tocopherol in-
creasing linearly relative to the concentration of the
homologue present at the start of the 24 h incubation.
The LDL receptor binding activity (Fig. 4A), protein (Fig.
4B) and mRNA (Fig. 4C) were increased 2, 4.5 and 7-fold
over control, respectively, at 50 µM α-tocopherol but were
reduced close to control levels at 100 µM α-tocopherol. In
contrast, LDL receptor binding activity (Fig. 4A), protein
(Fig. 4B) and mRNA (Fig. 4C) were reduced compared to
control at all concentrations of δ – and γ-tocopherol test-
ed. Therefore, like the biphasic regulation seen with α-to-
copherol, the downregulation observed with δ – and γ-
tocopherol appeared to be at the level of gene
transcription.
The tocopherols, at all concentrations, had no effect on
the growth of the HepG2 cells as judged by total cellular
Figure 3
The enrichment of HepG2 cells with different tocopherols. 
Cells were incubated for 24 h at 37°C in media containing 
the indicated concentrations of either α-tocopherol (● ), δ-
tocopherol (❍ ) or γ-tocopherol (▲ ). After 24 h, the toco-
pherols in the cells were measured by HPLC as described in 
Methods and materials. Values are means of duplicate 
determinations.
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Figure 4
The effects of different tocopherols on the LDL receptor 
binding activity, protein and mRNA of HepG2 cells. Cells 
were incubated for 24 h at 37°C in media containing the indi-
cated concentrations of either α-tocopherol (● ), δ-tocophe-
rol (❍ ) or γ-tocopherol (▲ ). The LDL receptor binding 
activity (A) was measured in triplicate using colloidal-gold 
LDL. The LDL receptor protein (B) was measured by west-
ern blotting and the LDL receptor mRNA (C) was measured 
using a PCR and western blotting technique as described in 
Methods and materials and the data was expressed as the 
percent difference from the values obtained with control 
cells not pretreated with α-tocopherol. The LDL receptor 
activity in control cells averaged 40 ± 5 ng LDL/mg cell pro-
tein, the LDL receptor protein in control cells averaged 0.85 
± 0.39 absorbance units and the amount of LDL receptor 
mRNA in control cells averaged 4.0 ± 0.5 × 10-5 copies/µg 
RNA.
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protein nor on cell viability as judged by the trypan blue
dye exclusion test.
Effects of α-tocopherol on the HMG-CoA reductase 
mRNA and on cell sterols
The HMG-CoA reductase reaction is the rate limiting step
in the de novo biosynthesis of cholesterol and regulation
of the enzyme is often in parallel to that of the LDL recep-
tor [20]. Vitamin E had the same biphasic effect on the
HMG-CoA reductase mRNA as it did on LDL receptor
binding activity, protein and mRNA. At 25 µM α-tocophe-
rol, the HMG CoA reductase mRNA was increased by 25 ±
2.5% over control, at 50 µM it was increased by 40 ± 3.5%
but at 100 µM it was close to control levels, only 3.2 ±
2.0% higher. The amount of HMG-CoA reductase mRNA
in control cells averaged 4.2 ± 0.8 × 105  copies/µg
RNA(Figure 5).
Consistent with the effects of vitamin E on the HMG-CoA
mRNA, the concentration of lathosterol in the cells, an in-
dicator of cholesterol synthesis, was also increased by
40% over control at 50 µM α-tocopherol but it was close
to control levels at 75 an 100 µM α-tocopherol (Fig. 6).
In contrast, the effects of vitamin E on the concentration
of cholesterol in the cells was inversely related to its effects
on cellular lathosterol (Fig. 6). At 50 µM α-tocopherol,
the cell cholesterol concentration was reduced by 20%
compared to control but it was close to control values at
75 and 100 µM α-tocopherol. Vitamin E however had lit-
tle effect on the cholesterol concentration in the media;
the values were 92%, 92%, 105% and 94% of control at
30, 50, 75 and 100 µM α-tocopherol, respectively. The
cholesterol concentration in the media of the control cells
was 25 µM.
Discussion
α-Tocopherol consistently modulated the expression of
the LDL receptor of HepG2 cells in a biphasic manner.
The receptor was progressively upregulated when the cells
were incubated with concentrations up to 50 µM α-toco-
pherol but it was downregulated towards control levels at
higher concentrations. The biphasic effect was observed
Figure 5
The effects of different tocopherols on HMG-CoA mRNA 
mRNA of HepG2 cells. Cells were incubated for 24 h at 
37°C in media containing the indicated concentrations of α-
tocopherol. HMG-CoA mRNA was measured using a PCR 
and western blotting technique as described in Methods and 
materials and the data was expressed as the percent differ-
ence from the values obtained with control cells not pre-
treated with α-tocopherol. The HMG-CoA mRNA in 
control cells averaged 4.2 ± 0.8 × 105 copies/µg RNA.
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Figure 6
The effect of α-tocopherol on the cellular concentration of 
cholesterol and lathosterol of HepG2 cells. Cells were incu-
bated for 24 h at 37°C in media containing the indicated con-
centrations of α-tocopherol. Cellular cholesterol (● ) and 
lathosterol (▲ ) were measured in duplicates by GC as 
described in Methods and materials and the data was 
expressed relative to the values of control cells not pre-
treated with α-tocopherol set at 100%. The cholesterol con-
centration in control cells was 9 mg/mg cell protein and the 
lathosterol concentration was 13 µg/mg cell protein.
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whether LDL receptor binding activity, protein or mRNA
was measured. The upregulation phase was specific for α-
tocopherol in that only downregulation of the LDL recep-
tor was observed with δ- and γ-tocopherol at comparable
concentrations. The α-tocopherol also had the same bi-
phasic effect on the mRNA of HMG-CoA reductase, the
rate-limiting enzyme in cholesterol biosynthesis [20] and
on the cellular lathosterol concentration, another index of
cholesterol synthesis. [33,34] The cell cholesterol concen-
tration may have mediated the biphasic "up-then-down"
effects on the LDL receptor and on cholesterol synthesis
because δ-tocopherol had an inverse "down-then up" ef-
fect on the cell cholesterol concentration.
The parallel biphasic modulation by α-tocopherol of LDL
receptor binding activity, protein and mRNA suggests that
the effect was at the level of gene transcription. For the
same reason, the downregulation observed with δ- and γ-
tocopherol also appeared to be at the level of gene
transcription. This is consistent with what is known about
the regulation of the LDL receptor [20], it is well docu-
mented to be at the level of gene transcription whether it
is dependent [35] or independent [36] of sterols. The con-
comitant "up-then-down" biphasic change in the HMG-
CoA reductase mRNA observed with α-tocopherol also
suggests that the transcription of both the LDL receptor
and the HMG-CoA reductase genes was coordinately up-
regulated. This parallel regulation fits very well with the
"down-then-up' effects of vitamin E on the cellular choles-
terol concentration as both genes are known to respond to
the same sterol feedback regulatory system [35,37]. Fur-
thermore, the same "up-then-down" effect on the cellular
lathosterol concentration indicates that the changes in
HMG-CoA reductase mRNA were translated into parallel
changes in cholesterol synthesis.
The upregulation of the LDL receptor by concentrations of
α-tocopherol up to 50 µM is consistent with a report on
the effect of γ-tocotrienol, a natural farnesylated analogue
of the tocopherols [18] on the LDL receptor. In that study,
10 µM γ-tocotrienol, the only concentration tested, in-
creased the amount of LDL receptor protein in HepG2
cells by 75% over control [38]. The tocotrienol also slight-
ly decreased the HMG-CoA reductase mRNA and
inhibited cholesterol synthesis by further inhibiting HMG
CoA reductase activity at a post-transcriptional level [38].
In contrast, in the present study, there was an increase in
cellular lathosterol concentration, an index of cholesterol
synthesis [33,34]. The results herein are also not consist-
ent with the evidence that vitamin E decreases cholesterol
synthesis in vitamin E-deficient rabbits [5].
The "up then down" regulation seen with α-tocopherol is
a novel observation for the LDL receptor and cholesterol
synthesis. However, the vitamin E homologue has
previously been found to have concentration-dependent
biphasic "up then down" effects on phospholipase A2 ac-
tivity [39] and on the synthesis of prostagladins [40] and
prostacyclins [41]. There have also been reports that pros-
taglandins can upregulate the LDL receptor, an effect that
appears to be mediated through camp [42,43]. However,
in contrast to the present findings, the effects on prostag-
landin synthesis were not specific to α-tocopherol in that
the β, δ and γ tocopherols also had biphasic "up then
down" effects [40]. Vitamin E is also known to have effects
on other cellular regulatory systems including the protein
kinase C (PKC) signalling pathway [44] which is also in-
volved in the regulation of the LDL receptor [36,45].
Clearly, there are a number of regulatory pathways
through which α-tocopherol could have effects on the
LDL receptor. The present observations are therefore gen-
erally consistent with what is already known about the ef-
fects of vitamin E on cellular metabolism.
The observed upregulation of the LDL receptor at concen-
trations from 0 to 50 µM α-tocopherol offers an explana-
tion for the high plasma cholesterol seen in vitamin E-
deficient animals and its lowering by replenishment with
the vitamin [1–7]. Tocopherols were undetectable when
the HepG2 cells were grown in the absence of added toco-
pherols; these cells therefore essentially mimic liver cells
in vitamin E-deficient animals. If replenishment with α-
tocopherol in deficient animals upregulates the hepatic
LDL receptor as it does in the vitamin E-free HepG2 cells,
then the clearance of LDL and other lipoproteins from the
circulation should increase [19,20] and contribute to the
lowering of the high plasma cholesterol seen in vitamin E-
deficient animals.
The biphasic "up then down" nature of the LDL receptor
response to the increasing α-tocopherol concentrations in
the present study may also explain the variable effects that
dietary supplementation with vitamin E can have on plas-
ma cholesterol when animals are not deficient in the vita-
min. In such animals made hypercholesterolaemic by
diet, α-tocopherol supplementation can result in 1) a de-
crease [8,12], 2) an increase [16] or 3) no change [13–15]
in plasma cholesterol. The present results would suggest
that the vitamin E level prior to supplementation could
have been 1) lower than optimal, 2) optimal or 3) higher
than optimal for maximal LDL receptor activity, respec-
tively and thus result in 1) an increase, 2) a decrease or 3)
no change in LDL receptor activity, respectively, upon
supplementation.
In humans, vitamin E deficiency is very rare and plasma
levels of the vitamin are generally higher than in animals.
Nonetheless, in a recent placebo controlled, cross-over
human trial, doses of vitamin E (73.5 mg /day for 6
weeks) was observed to significantly decrease plasma cho-Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/3
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lesterol by 5.3% and plasma triglycerides by 18.3% while
increasing the plasma α-tocopherol from 26.8 to 32.2 µM
[46], concentrations within the range where the increase
in the LDL receptor was observed in the present study. In
the same study, 500 mg/day of vitamin C also decreased
plasma cholesterol by 6.2% and triglycerides by 8.5%.
However, other recent human intervention studies with
generally higher vitamin E doses have mostly shown no
change or an increase in plasma cholesterol [47–50].
Importantly, the increase in plasma cholesterol, when
seen, is due mainly to an increase in high density lipopro-
tein (HDL) cholesterol, a lipoprotein which is considered
to be anti-atherogenic [50]. Why HDL cholesterol is in-
creased rather than LDL cholesterol, as might be expected
if the LDL receptor is decreased, is unclear. However, the
LDL receptor is only one of the factors which can affect
plasma cholesterol, and α-tocopherol may have effects on
other aspects of cholesterol and lipoprotein metabolism.
In conclusion, α-tocopherol has been shown to have a
concentration-dependent biphasic "up then down" effect
on the LDL receptor of HepG2 cells. The effect appears to
be at the level of gene transcription and is specific for α-
tocopherol in that δ – and γ-tocopherol only had down-
regulatory effects. The α-tocopherol also had the same ef-
fects on HMG-CoA reductase mRNA levels and the
cellular lathosterol concentration, indices of cholesterol
synthesis. These vitamin E effects may have been mediat-
ed through the observed "down-then-up" effect on the
cellular cholesterol concentration. These results may ex-
plain the hypercholesterolaemia observed in animal mod-
els of vitamin E deficiency and may be relevant to the
variable effect α-tocopherol supplementation has on
plasma cholesterol in animals and humans not deficient
in the vitamin.
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